Marine pharmacognosy

Marine Pharmacognosy is a sub-discipline of Pharmacognosy that deals with the study of medicinal or bioactive compounds derived from marine organisms. This field of study is gaining importance due to the increasing need for novel drugs and therapies in the medical field.

Overview

Marine Pharmacognosy involves the study of marine organisms such as algae, sponges, corals, mollusks, crustaceans, echinoderms, tunicates, and fish for the purpose of discovering and developing new pharmaceuticals. The marine environment is a rich source of both biological and chemical diversity, which makes it an excellent resource for the discovery of new drugs and therapies.

History

The history of Marine Pharmacognosy dates back to the ancient times when people used marine organisms for medicinal purposes. However, the systematic study and exploration of marine organisms for drug discovery started in the 20th century. The first marine-derived drug to be approved by the FDA was Cytarabine, a cancer drug derived from a sponge.

Current Research

Current research in Marine Pharmacognosy is focused on the discovery of new drugs from marine organisms. Several marine-derived drugs are currently in clinical trials for various diseases including cancer, infectious diseases, neurological disorders, and cardiovascular diseases.

Challenges

Despite the potential of marine organisms as a source of new drugs, there are several challenges in the field of Marine Pharmacognosy. These include the difficulty in collecting marine organisms, the complexity of marine ecosystems, and the ethical and legal issues related to the exploitation of marine resources.

See Also

• Pharmacognosy
• Marine Biology
• Drug Discovery
• Medicinal Chemistry

File:WHO Rod.svg This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

• Halichondria and Eribulin
  Halichondria and Eribulin